The feasibility and added value of indocyanine green tracing in guiding sentinel lymph node biopsy for breast cancer

Objective: To compare the effectiveness of combined (indocyanine green [ICG]+ blue dye) tracing versus blue dye alone in guiding sentinel lymph node biopsy (SLNB) in breast cancer. Methods: A total of 112 female patients (mean ± SD age: 51.9 ± 11.9 years) with clinically node-negative (cN0) early-st...

Full description

Saved in:
Bibliographic Details
Main Authors: Ercument Gurluler, Volkan Polatkan, Kazim Senol, Mustafa Sehsuvar Gokgoz
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Asian Journal of Surgery
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S101595842401460X
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846148960968769536
author Ercument Gurluler
Volkan Polatkan
Kazim Senol
Mustafa Sehsuvar Gokgoz
author_facet Ercument Gurluler
Volkan Polatkan
Kazim Senol
Mustafa Sehsuvar Gokgoz
author_sort Ercument Gurluler
collection DOAJ
description Objective: To compare the effectiveness of combined (indocyanine green [ICG]+ blue dye) tracing versus blue dye alone in guiding sentinel lymph node biopsy (SLNB) in breast cancer. Methods: A total of 112 female patients (mean ± SD age: 51.9 ± 11.9 years) with clinically node-negative (cN0) early-stage breast cancer were evaluated based on SLN tracing technique including methylene blue + ICG (n = 17), isosulfan blue + ICG (n = 19) and methylene blue alone (n = 76). Mapping patterns of each SLN, the number of total lymph nodes (TLNs) removed, including metastatic and hyperplastic lymph nodes, and the metastatic lymph node detection rate were analyzed for each tracing technique. Results: SLN detection rate was 100 % with complementary use of ICG. No significant difference was noted between methylene blue + ICG, isosulfan + ICG and methylene blue alone groups in terms of the mean ± SD number of TLNs removed (3.9 ± 2.5, 4.7 ± 3 and 3.7 ± 2.3, respectively) and metastatic lymph node detection rates (16.0 %, 16.25 % and 13.98 %, respectively). Complementary use of ICG revealed the N0 stage for 66.6 % of cases considered as Nx (cannot be detected) on blue dye alone. Also, 20.0 % of N0 and 11.1 % of N1 cases on blue dye were diagnosed with more advance nodal status (N1 and N2 respectively) after complementary use of ICG. Conclusions: The combined tracing (ICG + blue dye) seems valuable not only in terms of the SLN detection rates and lymph node yield but also has an added value in providing more accurate nodal stating and thus a proper final tumor staging with considerable therapeutic implications.
format Article
id doaj-art-881e7abd16f947f88d0b3e9cb6c6fcf1
institution Kabale University
issn 1015-9584
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series Asian Journal of Surgery
spelling doaj-art-881e7abd16f947f88d0b3e9cb6c6fcf12024-11-30T07:09:36ZengElsevierAsian Journal of Surgery1015-95842024-12-01471251315136The feasibility and added value of indocyanine green tracing in guiding sentinel lymph node biopsy for breast cancerErcument Gurluler0Volkan Polatkan1Kazim Senol2Mustafa Sehsuvar Gokgoz3Corresponding author. Department of General Surgery, Uludag University Faculty of Medicine, Görükle Kampüsü, 16059, Nilüfer, Bursa, Turkey.; Department of General Surgery, Bursa Uludag University Faculty of Medicine, Bursa, TurkeyDepartment of General Surgery, Bursa Uludag University Faculty of Medicine, Bursa, TurkeyDepartment of General Surgery, Bursa Uludag University Faculty of Medicine, Bursa, TurkeyDepartment of General Surgery, Bursa Uludag University Faculty of Medicine, Bursa, TurkeyObjective: To compare the effectiveness of combined (indocyanine green [ICG]+ blue dye) tracing versus blue dye alone in guiding sentinel lymph node biopsy (SLNB) in breast cancer. Methods: A total of 112 female patients (mean ± SD age: 51.9 ± 11.9 years) with clinically node-negative (cN0) early-stage breast cancer were evaluated based on SLN tracing technique including methylene blue + ICG (n = 17), isosulfan blue + ICG (n = 19) and methylene blue alone (n = 76). Mapping patterns of each SLN, the number of total lymph nodes (TLNs) removed, including metastatic and hyperplastic lymph nodes, and the metastatic lymph node detection rate were analyzed for each tracing technique. Results: SLN detection rate was 100 % with complementary use of ICG. No significant difference was noted between methylene blue + ICG, isosulfan + ICG and methylene blue alone groups in terms of the mean ± SD number of TLNs removed (3.9 ± 2.5, 4.7 ± 3 and 3.7 ± 2.3, respectively) and metastatic lymph node detection rates (16.0 %, 16.25 % and 13.98 %, respectively). Complementary use of ICG revealed the N0 stage for 66.6 % of cases considered as Nx (cannot be detected) on blue dye alone. Also, 20.0 % of N0 and 11.1 % of N1 cases on blue dye were diagnosed with more advance nodal status (N1 and N2 respectively) after complementary use of ICG. Conclusions: The combined tracing (ICG + blue dye) seems valuable not only in terms of the SLN detection rates and lymph node yield but also has an added value in providing more accurate nodal stating and thus a proper final tumor staging with considerable therapeutic implications.http://www.sciencedirect.com/science/article/pii/S101595842401460XBreast cancerSentinel lymph node biopsyIndocyanine greenLymph node yieldAxillary staging
spellingShingle Ercument Gurluler
Volkan Polatkan
Kazim Senol
Mustafa Sehsuvar Gokgoz
The feasibility and added value of indocyanine green tracing in guiding sentinel lymph node biopsy for breast cancer
Asian Journal of Surgery
Breast cancer
Sentinel lymph node biopsy
Indocyanine green
Lymph node yield
Axillary staging
title The feasibility and added value of indocyanine green tracing in guiding sentinel lymph node biopsy for breast cancer
title_full The feasibility and added value of indocyanine green tracing in guiding sentinel lymph node biopsy for breast cancer
title_fullStr The feasibility and added value of indocyanine green tracing in guiding sentinel lymph node biopsy for breast cancer
title_full_unstemmed The feasibility and added value of indocyanine green tracing in guiding sentinel lymph node biopsy for breast cancer
title_short The feasibility and added value of indocyanine green tracing in guiding sentinel lymph node biopsy for breast cancer
title_sort feasibility and added value of indocyanine green tracing in guiding sentinel lymph node biopsy for breast cancer
topic Breast cancer
Sentinel lymph node biopsy
Indocyanine green
Lymph node yield
Axillary staging
url http://www.sciencedirect.com/science/article/pii/S101595842401460X
work_keys_str_mv AT ercumentgurluler thefeasibilityandaddedvalueofindocyaninegreentracinginguidingsentinellymphnodebiopsyforbreastcancer
AT volkanpolatkan thefeasibilityandaddedvalueofindocyaninegreentracinginguidingsentinellymphnodebiopsyforbreastcancer
AT kazimsenol thefeasibilityandaddedvalueofindocyaninegreentracinginguidingsentinellymphnodebiopsyforbreastcancer
AT mustafasehsuvargokgoz thefeasibilityandaddedvalueofindocyaninegreentracinginguidingsentinellymphnodebiopsyforbreastcancer
AT ercumentgurluler feasibilityandaddedvalueofindocyaninegreentracinginguidingsentinellymphnodebiopsyforbreastcancer
AT volkanpolatkan feasibilityandaddedvalueofindocyaninegreentracinginguidingsentinellymphnodebiopsyforbreastcancer
AT kazimsenol feasibilityandaddedvalueofindocyaninegreentracinginguidingsentinellymphnodebiopsyforbreastcancer
AT mustafasehsuvargokgoz feasibilityandaddedvalueofindocyaninegreentracinginguidingsentinellymphnodebiopsyforbreastcancer